# Pioglitazone to Treat Fatty Liver in People With HIV Infection

> **NCT00441272** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 100 (actual)

## Conditions studied

- HIV Infections
- Hepatic Steatosis
- Insulin Resistance

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00441272
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2010-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441272, "Pioglitazone to Treat Fatty Liver in People With HIV Infection". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00441272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*